For instance, the breast cancer cells could induce multidrug resistance mediator GPER translocation in CAFs, stimulating a novel estrogen/GPER/PKA/CREB signaling activation, thereby contributing to glycolytic CAFs for the production of energy-enriched pyruvate and lactate. Here, GPER1 is linked to breast cancer.